186 related articles for article (PubMed ID: 31686603)
1. Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions.
Kim TI; Chen JF; Orion KC
Vasc Med; 2019 Dec; 24(6):528-535. PubMed ID: 31686603
[TBL] [Abstract][Full Text] [Related]
2. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.
Singh N; Ding L; Magee GA; Shavelle DM; Kashyap VS; Garg PK
Circ Cardiovasc Interv; 2020 Aug; 13(8):e008791. PubMed ID: 32791948
[TBL] [Abstract][Full Text] [Related]
3. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.
Cho S; Lee YJ; Ko YG; Kang TS; Lim SH; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2019 Dec; 12(23):2359-2370. PubMed ID: 31734299
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dual-antiplatelet therapy durations after endovascular revascularization of infrainguinal arteries.
Sarode K; Mohammad A; Das S; Vinas A; Banerjee A; Tsai S; Armstrong EJ; Shammas NW; Klein A; Brilakis ES; Banerjee S
Ann Vasc Surg; 2015 Aug; 29(6):1235-44. PubMed ID: 26026491
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
[TBL] [Abstract][Full Text] [Related]
6. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
[TBL] [Abstract][Full Text] [Related]
7. Effects of dual antiplatelet therapy on graft patency after lower extremity bypass.
Belkin N; Stoecker JB; Jackson BM; Damrauer SM; Glaser J; Kalapatapu V; Golden MA; Wang GJ
J Vasc Surg; 2021 Mar; 73(3):930-939. PubMed ID: 32777321
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and anticoagulation therapy after revascularization for lower extremity artery disease: a national survey and literature overview.
Ipema J; Brand AR; DE Borst GJ; DE Vries JP; ÜnlÜ Ç
J Cardiovasc Surg (Torino); 2021 Feb; 62(1):59-70. PubMed ID: 33112125
[TBL] [Abstract][Full Text] [Related]
9. Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries.
Kronlage M; Wassmann M; Vogel B; Müller OJ; Blessing E; Katus H; Erbel C
Drug Des Devel Ther; 2017; 11():2937-2945. PubMed ID: 29062225
[TBL] [Abstract][Full Text] [Related]
10. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
[TBL] [Abstract][Full Text] [Related]
13. Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.
Soden PA; Zettervall SL; Curran T; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
J Vasc Surg; 2017 Jan; 65(1):108-118. PubMed ID: 27692467
[TBL] [Abstract][Full Text] [Related]
14. Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery.
Mori M; Shioda K; Yun JJ; Mangi AA; Darr U; Geirsson A
J Thorac Cardiovasc Surg; 2018 Feb; 155(2):632-638. PubMed ID: 29056263
[TBL] [Abstract][Full Text] [Related]
15. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
[TBL] [Abstract][Full Text] [Related]
16. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830
[TBL] [Abstract][Full Text] [Related]
17. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study.
Zheng B; Huo Y; Lee SW; Sawhney JPS; Kim HS; Krittayaphong R; Pocock SJ; Nhan VT; Alonso Garcia A; Chin CT; Jiang J; Jan S; Vega AM; Hayashi N; Ong TK
Clin Cardiol; 2020 Sep; 43(9):999-1008. PubMed ID: 32618009
[TBL] [Abstract][Full Text] [Related]
18. Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study.
Angerås O; Hasvold P; Thuresson M; Deleskog A; ÖBraun O
Scand Cardiovasc J; 2016; 50(2):99-107. PubMed ID: 26564402
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.
Singh N; Ding L; Devera J; Magee GA; Garg PK
JAMA Netw Open; 2021 Dec; 4(12):e2136014. PubMed ID: 34860245
[TBL] [Abstract][Full Text] [Related]
20. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.
Navarese EP; Wernly B; Lichtenauer M; Petrescu AM; Kołodziejczak M; Lauten A; Frediani L; Veulemanns V; Wanha W; Wojakowski W; Lesiak M; Ferrante G; Zeus T; Tantry U; Bliden K; Buffon A; Contegiacomo G; Jung C; Kubica J; Pestrichella V; Gurbel PA
Int J Cardiol; 2018 Oct; 269():292-297. PubMed ID: 30045826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
